Renalytix plc Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Renalytix plc (RENXF) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $9.80 million for the 12-month period ending 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2024-09-30
- Renalytix plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $9.80M, a 32.41% decline from fiscal 2023.
- Renalytix plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $14.50M, a 43.56% increase from fiscal 2022.
- Renalytix plc valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $10.10M.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 4 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|---|
| 2024-06-30 | $9.80M 10-K · filed 2024-09-30 | |
| 2023-06-30 | $14.50M 10-K · filed 2024-09-30 | |
| 2022-06-30 | $10.10M 10-K · filed 2023-09-28 | |
| 2021-06-30 | $13.70M 20-F · filed 2022-10-31 | |
| 2020-06-30 | $2.30M 20-F · filed 2022-10-31 | |
| 2019-06-30 | $4.80M 20-F/A · filed 2020-11-10 | |
| 2018-06-30 | $200.00K 20-F/A · filed 2020-11-10 |